Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000428139 | SCV000524356 | benign | not specified | 2016-10-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000428139 | SCV000711763 | benign | not specified | 2018-01-23 | criteria provided, single submitter | clinical testing | p.Arg1412Trp in exon 6 of ALPK3: This variant is not expected to have clinical s ignificance because it has been identified in 7.4% (153/2070) of African chromos omes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs55752937). |
Invitae | RCV002062648 | SCV002487092 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328954 | SCV002632819 | benign | Cardiovascular phenotype | 2018-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003114551 | SCV003799295 | benign | Cardiomyopathy, familial hypertrophic 27 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000428139 | SCV004038219 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing |